OTCMKTS:MYRX - Myrexis Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Myrexis Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.03 0.00 (0.00 %) (As of 01/24/2020 03:48 PM ET) Add Compare Today's Range$0.03Now: $0.03▼$0.0350-Day Range$0.02MA: $0.02▼$0.0352-Week Range$0.01Now: $0.03▼$0.06Volume61,478 shsAverage Volume85,382 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABeta3.31 ProfileAdvanced ChartDividendEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MYRX Previous Symbol CUSIPN/A CIK1459450 Webhttp://www.myrexis.com/ Phone801-214-7800Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive MYRX News and Ratings via Email Sign-up to receive the latest news and ratings for MYRX and its competitors with MarketBeat's FREE daily newsletter. OTC:MYRX Rates by TradingView Myrexis (OTCMKTS:MYRX) Frequently Asked Questions What is Myrexis' stock symbol? Myrexis trades on the OTCMKTS under the ticker symbol "MYRX." Has Myrexis been receiving favorable news coverage? Media headlines about MYRX stock have been trending somewhat negative recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Myrexis earned a media sentiment score of -1.0 on InfoTrie's scale. They also gave media coverage about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Myrexis. Who are some of Myrexis' key competitors? Some companies that are related to Myrexis include 89bio (ETNB), Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), American Oriental Bioengineering (AOBI), Aoxing Pharmaceutical (AOXG), Bohai Pharmaceuticals Group (BOPH), Eleven Biotherapeutics (EBIO), Epirus Biopharmaceuticals (EPRSQ), ERBA Diagnostics (ERBA), FutureWorld (FWDG), GlobeImmune (GBIM), Mereo BioPharma Group (MREO), NeuroVive Pharmaceutical (NEVPF), Pivotal Therapeutics (PVTTF) and Poniard Pharmaceuticals (PARD). What other stocks do shareholders of Myrexis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Myrexis investors own include Histogenics (HSGX), Propanc Biopharma (PPCB), Leidos (LDOS), VAALCO Energy (EGY), Canopy Growth (CGC), Berry Petroleum (BRY), BIOLINERX LTD/S (BLRX), Amarin (AMRN), Grafenia (GRA) and New Age Brands (NF). Who are Myrexis' key executives? Myrexis' management team includes the folowing people: Mr. Jonathan M. Couchman, Chairman, CEO, Pres, CFO & Principal Accounting Officer (Age 49) How do I buy shares of Myrexis? Shares of MYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Myrexis' stock price today? One share of MYRX stock can currently be purchased for approximately $0.03. What is Myrexis' official website? The official website for Myrexis is http://www.myrexis.com/. How can I contact Myrexis? Myrexis' mailing address is C/O XSTELOS HOLDINGS INC. 630 FIFTH AVENUE SUITE 2260, NEW YORK NY, 10020. The biopharmaceutical company can be reached via phone at 801-214-7800 or via email at [email protected] MarketBeat Community Rating for Myrexis (OTCMKTS MYRX)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 72 (Vote Outperform)Underperform Votes: 61 (Vote Underperform)Total Votes: 133MarketBeat's community ratings are surveys of what our community members think about Myrexis and other stocks. Vote "Outperform" if you believe MYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYRX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/24/2020 by MarketBeat.com StaffFeatured Article: How interest rates affect municipal bond prices
